$GEVO
Gevo, Inc. Stock $gevo

$gevo Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000139238024000008 Filed on March 07, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$3.990M	$4.374M	$17.20M
YoY Change	-1.72%	702.57%	1363.83%
Cost Of Revenue	$3.663M	$4.272M	$16.03M
YoY Change	-32.47%	86.06%	20.56%
Gross Profit	$327.0K	$102.0K	$1.169M
YoY Change	-123.97%	-105.83%	-109.64%
Gross Profit Margin	8.2%	2.33%	6.8%
Selling, General & Admin	$12.15M	$10.74M	$42.63M
YoY Change	12.91%	0.01%	6.73%
% of Gross Profit	3715.6%	10526.47%	3646.54%
Research & Development	$1.548M	$1.921M	$6.637M
YoY Change	29.22%	-29.04%	-10.64%
% of Gross Profit	473.39%	1883.33%	567.75%
Depreciation & Amortization	$4.451M	$4.684M	$19.01M
YoY Change	-2.71%	36.36%	140.99%
% of Gross Profit	1361.16%	4592.16%	1625.92%
Operating Expenses	$1.548M	$21.44M	$6.637M
YoY Change	29.22%	-13.19%	-10.64%
Operating Profit	-$23.14M	-$21.34M	-$81.84M
YoY Change	10.95%	-19.32%	-20.31%
Interest Expense	$542.0K	$4.461M	$2.161M
YoY Change	0.56%	96.35%	85.18%
% of Operating Profit
Other Income/Expense, Net	$4.266M	-$1.601M	$15.62M
YoY Change	31.71%	124.86%	233.83%
Pretax Income	-$18.88M	-$18.48M	-$66.22M
YoY Change	7.13%	-27.22%	-32.44%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$18.88M	-$18.48M	-$66.22M
YoY Change	7.13%	-27.22%	-32.44%
Net Earnings / Revenue	-473.06%	-422.43%	-384.97%
Basic Earnings Per Share	-$0.08		-$0.28
Diluted Earnings Per Share	-$0.08	-$0.08	-$0.28
COMMON SHARES
Basic Shares Outstanding	240.5M	240.3M	238.7M
Diluted Shares Outstanding	240.8M		238.7M

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$270.6M	$298.3M	$298.3M
YoY Change	-27.86%	-26.24%	-26.25%
Cash & Equivalents	$270.6M	$298.3M	$298.3M
Short-Term Investments		$0.00	$0.00
Other Short-Term Assets	$1.290M	$81.60M	$80.27M
YoY Change	-78.56%	1906.91%	1874.18%
Inventory	$3.762M	$3.809M	$3.809M
Prepaid Expenses
Receivables	$2.488M	$2.623M	$2.623M
Other Receivables	$1.195M	$0.00	$1.331M
Total Short-Term Assets	$282.3M	$386.4M	$386.4M
YoY Change	-26.94%	-6.99%	-6.99%
LONG-TERM ASSETS
Property, Plant & Equipment	$227.7M	$211.6M	$213.1M
YoY Change	23.83%	19.61%	19.43%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$115.9M	$44.32M	$44.32M
YoY Change	5.79%	-55.33%	-55.33%
Total Long-Term Assets	$351.3M	$263.9M	$263.9M
YoY Change	16.2%	-7.5%	-7.5%
TOTAL ASSETS
Total Short-Term Assets	$282.3M	$386.4M	$386.4M
Total Long-Term Assets	$351.3M	$263.9M	$263.9M
Total Assets	$633.6M	$650.3M	$650.3M
YoY Change	-8.0%	-7.2%	-7.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.600M	$2.718M	$2.718M
YoY Change	-6.69%	-45.74%	-45.74%
Accrued Expenses	$4.882M	$13.41M	$20.57M
YoY Change	-77.29%	6.49%	1.87%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$118.0K	$68.10M	$68.14M
YoY Change	-22.37%	42728.3%	28531.09%
Total Short-Term Liabilities	$22.06M	$91.43M	$91.43M
YoY Change	-13.69%	259.44%	259.44%
LONG-TERM LIABILITIES
Long-Term Debt	$68.16M	$21.00K	$208.0K
YoY Change	0.92%	-99.97%	-99.69%
Other Long-Term Liabilities	$1.222M	$1.299M	$1.299M
YoY Change	118.21%	58.41%	-42.78%
Total Long-Term Liabilities	$68.16M	$21.00K	$1.507M
YoY Change	0.09%	-99.97%	-97.84%
TOTAL LIABILITIES
Total Short-Term Liabilities	$22.06M	$91.43M	$91.43M
Total Long-Term Liabilities	$68.16M	$21.00K	$1.507M
Total Liabilities	$91.63M	$92.93M	$92.93M
YoY Change	-3.79%	-2.45%	-2.45%
SHAREHOLDERS EQUITY
Retained Earnings	-$740.5M	-$721.6M
YoY Change	10.03%	10.1%
Common Stock	$2.396M	$2.405M
YoY Change	0.97%	1.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$541.9M	$557.4M	$557.4M
YoY Change
Total Liabilities & Shareholders Equity	$633.6M	$650.3M	$650.3M
YoY Change	-8.0%	-7.2%	-7.2%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$18.88M	-$18.48M	-$66.22M
YoY Change	7.13%	-27.22%	-32.44%
Depreciation, Depletion And Amortization	$4.451M	$4.684M	$19.01M
YoY Change	-2.71%	36.36%	140.99%
Cash From Operating Activities	-$16.08M	-$32.59M	-$53.72M
YoY Change	-17.32%	105.71%	2.1%
INVESTING ACTIVITIES
Capital Expenditures	$17.51M	-$6.958M	$54.46M
YoY Change	53.16%	-196.1%	-28.14%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$168.6M
YoY Change	-100.0%	-100.0%	-0.35%
Cash From Investing Activities	-$17.51M	$6.958M	$114.1M
YoY Change	-114.1%	-85.66%	22.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.452M	-39.00K	-189.0K
YoY Change	2241.94%	-100.91%	-100.14%
NET CHANGE
Cash From Operating Activities	-16.08M	-32.59M	-53.72M
Cash From Investing Activities	-17.51M	6.958M	114.1M
Cash From Financing Activities	-1.452M	-39.00K	-189.0K
Net Change In Cash	-35.04M	-25.67M	60.22M
YoY Change	-133.48%	-169.49%	-66.42%
FREE CASH FLOW
Cash From Operating Activities	-$16.08M	-$32.59M	-$53.72M
Capital Expenditures	$17.51M	-$6.958M	$54.46M
Free Cash Flow	-$33.59M	-$25.63M	-$108.2M
YoY Change	8.78%	11.05%	-15.74%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	238687621
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	221537262
CY2022Q4	gevo	Indemnification Liabilities IndemnificationLiabilities	0
CY2023Q4	gevo	Indemnification Liabilities IndemnificationLiabilities	0
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001392380
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	237166625
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	240499833
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.44
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P3Y
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-66215000
CY2023Q4	us-gaap	Assets Current AssetsCurrent	386382000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-98007000
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.44
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	0
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-35073
CY2023	dei	Entity Registrant Name EntityRegistrantName	GEVO, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-0747704
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	345 Inverness Drive South
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Building C, Suite 310
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Englewood
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80112
CY2023	dei	City Area Code CityAreaCode	303
CY2023	dei	Local Phone Number LocalPhoneNumber	858-8358
CY2023	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
CY2023	dei	Trading Symbol TradingSymbol	GEVO
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	true
CY2023	dei	Document Fin Stmt Restatement Recovery Analysis Flag DocumentFinStmtRestatementRecoveryAnalysisFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	400000000
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	240499833
CY2023	dei	Auditor Firm AuditorFirmId	248
CY2023	dei	Auditor Name AuditorName	GRANT THORNTON LLP
CY2023	dei	Auditor Location AuditorLocation	Denver, Colorado
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	298349000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	237125000
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	167408000
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	77248000
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	1032000
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2623000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	476000
CY2023Q4	us-gaap	Inventory Net InventoryNet	3809000
CY2022Q4	us-gaap	Inventory Net InventoryNet	6347000
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4353000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3034000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	415422000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	211563000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	185174000
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	77219000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1324000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1331000
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	210000
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	219000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6524000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7691000
CY2023Q4	gevo	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	44319000
CY2022Q4	gevo	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	13692000
CY2023Q4	us-gaap	Assets Assets	650322000
CY2022Q4	us-gaap	Assets Assets	700748000
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	22752000
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	24760000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	532000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	438000
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	45000
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	79000
CY2023Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	130000
CY2022Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	159000
CY2023Q4	us-gaap	Longterm Pollution Control Bond Current LongtermPollutionControlBondCurrent	67967000
CY2022Q4	us-gaap	Longterm Pollution Control Bond Current LongtermPollutionControlBondCurrent	0
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	91426000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	25436000
CY2022Q4	us-gaap	Long Term Pollution Control Bond LongTermPollutionControlBond	67223000
CY2023Q4	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	21000
CY2022Q4	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	159000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1299000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1450000
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	187000
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	183000
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	820000
CY2023Q4	us-gaap	Liabilities Liabilities	92933000
CY2022Q4	us-gaap	Liabilities Liabilities	95271000
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	240499833
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	237166625
CY2023Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	2405000
CY2022Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	2372000
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1276581000
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1259527000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1040000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-721597000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-655382000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	557389000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	605477000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	650322000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	700748000
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	17200000
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1175000
CY2023	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	11991000
CY2022	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	8698000
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	19007000
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7887000
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6637000
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7427000
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	42628000
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	39941000
CY2023	gevo	Project Development Costs ProjectDevelopmentCosts	14732000
CY2022	gevo	Project Development Costs ProjectDevelopmentCosts	10061000
CY2023	gevo	Idle Facility Costs IdleFacilityCosts	4040000
CY2022	gevo	Idle Facility Costs IdleFacilityCosts	4599000
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	24749000
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-499000
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	99035000
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	103861000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-81835000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-102686000
CY2023	us-gaap	Interest Expense InterestExpense	2161000
CY2022	us-gaap	Interest Expense InterestExpense	1167000
CY2023	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	19090000
CY2022	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	3481000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1309000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2365000
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	15620000
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4679000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-66215000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-98007000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.44
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.44
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	238687621
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	238687621
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	221537262
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	221537262
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-66215000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-98007000
CY2023	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	1040000
CY2022	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-426000
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-65175000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-98433000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	547255000
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	139008000
CY2022	gevo	Stock Issued During Period Values Warrants Exercised StockIssuedDuringPeriodValuesWarrantsExercised	3000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	17419000
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	225000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-426000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-98007000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	605477000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	17087000
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1040000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-66215000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	557389000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-66215000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-98007000
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	24749000
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-499000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	17087000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	17419000
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	19007000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7887000
CY2023	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	102000
CY2022	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-2723000
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-908000
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-877000
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2147000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-502000
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-670000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2004000
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	25620000
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2591000
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2693000
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3635000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-53719000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-44311000
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	54455000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	84077000
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	10000
CY2023	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	168550000
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	299581000
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	130402000
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	34000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	114129000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	85092000
CY2022	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	10993000
CY2022	gevo	Proceeds From Issuance Of Common Stock And Common Stock Warrants ProceedsFromIssuanceOfCommonStockAndCommonStockWarrants	150000000
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3000
CY2022	gevo	Payments For Net Settlement Of Common Stock Under Stock Plans PaymentsForNetSettlementOfCommonStockUnderStockPlans	286000
CY2023	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	167000
CY2022	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	150000
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	22000
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	12000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-189000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	138562000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	60221000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	179343000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	315376000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	136033000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	375597000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	315376000
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	298349000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	237125000
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	77248000
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	1032000
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	77219000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	375597000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	315376000
CY2023	us-gaap	Interest Paid Net InterestPaidNet	1029000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	522000
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	8174000
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	13837000
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	199000
CY2023Q4	gevo	Renewable Natural Gas Supplies Number Of Dairies RenewableNaturalGasSuppliesNumberOfDairies	3
CY2023	gevo	Renewable Natural Gas Facilities Original Design Capacity RenewableNaturalGasFacilitiesOriginalDesignCapacity	355000
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	298300000
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	77200000
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 10pt 0pt;"><i style="font-style:italic;">Reclassifications.</i> The Company reclassified certain prior period amounts to conform to the current period presentation. The reclassifications included the categorization of depreciation and amortization on the Consolidated Statements of Operations and had no impact on total revenues, total operating expenses, net loss or stockholders’ equity for any period.</p>
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 10pt 0pt;"><i style="font-style:italic;">Use of Estimates</i>. The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.</p>
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 10pt 0pt;"><i style="font-style:italic;">Concentrations of Credit Risk and Major Customers</i>. The Company’s financial instruments that are exposed to concentrations of credit risk consist of cash and cash equivalents in excess of the federally insured limits. The Company’s cash and cash equivalents are deposited with high credit-quality financial institutions and are primarily in demand deposit accounts and money market funds. As of December 31, 2023, and 2022, <span style="-sec-ix-hidden:Hidden_MY9m8jx--0SKRsK0djbkyQ;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">one</span></span> customer accounted for 100% of trade accounts receivable, net, and 90% and 73% of total revenue, respectively.</p>
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	50373000
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	69245000
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	17200000
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1175000
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0
CY2023Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	24700000
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-66215000
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-98007000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	238687621
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	221537262
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.44
CY2023	us-gaap	Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments	0
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	168448000
CY2022Q4	gevo	Debt Securities Available For Sale Current Accumulated Gross Unrealized Loss Before Tax DebtSecuritiesAvailableForSaleCurrentAccumulatedGrossUnrealizedLossBeforeTax	1040000
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	167408000
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	800000
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	4300000
CY2023Q4	gevo	Restricted Cash For Letters Of Credit RestrictedCashForLettersOfCredit	77300000
CY2023	gevo	Restricted Cash Interest Income RestrictedCashInterestIncome	3400000
CY2022	gevo	Restricted Cash Interest Income RestrictedCashInterestIncome	500000
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	568000
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	911000
CY2023Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	1331000
CY2022Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	514000
CY2023Q4	gevo	Prepaid Feedstock Current PrepaidFeedstockCurrent	1097000
CY2022Q4	gevo	Prepaid Feedstock Current PrepaidFeedstockCurrent	1097000
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1357000
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	512000
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4353000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3034000
CY2023Q4	gevo	Lessee Finance Lease Number Of Contract LesseeFinanceLeaseNumberOfContract	4
CY2023Q4	gevo	Number Of Digester Sites NumberOfDigesterSites	3
CY2023Q4	gevo	Number Of Digester Sites NumberOfDigesterSites	3
CY2023	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	22000
CY2022	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	30000
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	330000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	928000
CY2023	gevo	Finance Leases Finance Cash Flows Net FinanceLeasesFinanceCashFlowsNet	2000
CY2022	gevo	Finance Leases Finance Cash Flows Net FinanceLeasesFinanceCashFlowsNet	2000
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	199000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P307M
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P311M
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P61M
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P65M
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.12
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.12
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.06
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.05
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	617000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	50000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	398000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	27000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	367000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	25000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	335000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	26000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	345000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	26000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	523000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2062000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	677000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	231000
CY2023Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	445000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1831000
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	232000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	532000
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	45000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1299000
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	187000
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	104000
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	168000
CY2023Q4	us-gaap	Inventory Parts And Components Net Of Reserves InventoryPartsAndComponentsNetOfReserves	471000
CY2022Q4	us-gaap	Inventory Parts And Components Net Of Reserves InventoryPartsAndComponentsNetOfReserves	354000
CY2023Q4	us-gaap	Inventory Net InventoryNet	3809000
CY2022Q4	us-gaap	Inventory Net InventoryNet	6347000
CY2023Q4	gevo	Inventory Value Adjustment Average Cost Method InventoryValueAdjustmentAverageCostMethod	1900000
CY2022Q4	gevo	Inventory Value Adjustment Average Cost Method InventoryValueAdjustmentAverageCostMethod	400000
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	297878000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	256813000
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	86315000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	71639000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	211563000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	185174000
CY2023	us-gaap	Depreciation Depreciation	17600000
CY2022	us-gaap	Depreciation Depreciation	6500000
CY2022	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	13800000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	9480000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2956000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6524000
CY2023	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P7Y10M24D
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	9480000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1789000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7691000
CY2022	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P7Y10M24D
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1200000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1300000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1168000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1168000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1168000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1168000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1168000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	684000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6524000
CY2023Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	166000
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	276000
CY2023Q4	gevo	Prepaid Feedstock Noncurrent PrepaidFeedstockNoncurrent	440000
CY2022Q4	gevo	Prepaid Feedstock Noncurrent PrepaidFeedstockNoncurrent	934000
CY2023Q4	gevo	Deposits And Other Assets Noncurrent Equity Interest DepositsAndOtherAssetsNoncurrentEquityInterest	1500000
CY2022Q4	gevo	Deposits And Other Assets Noncurrent Equity Interest DepositsAndOtherAssetsNoncurrentEquityInterest	1500000
CY2023Q4	gevo	Deposits And Other Assets Noncurrent Exclusivity Fees DepositsAndOtherAssetsNoncurrentExclusivityFees	583000
CY2022Q4	gevo	Deposits And Other Assets Noncurrent Exclusivity Fees DepositsAndOtherAssetsNoncurrentExclusivityFees	2522000
CY2023Q4	gevo	Deposits And Other Assets Noncurrent Deposits Receivable DepositsAndOtherAssetsNoncurrentDepositsReceivable	33602000
CY2022Q4	gevo	Deposits And Other Assets Noncurrent Deposits Receivable DepositsAndOtherAssetsNoncurrentDepositsReceivable	0
CY2023Q4	gevo	Deposits And Other Assets Noncurrent Other Assets Net DepositsAndOtherAssetsNoncurrentOtherAssetsNet	8028000
CY2022Q4	gevo	Deposits And Other Assets Noncurrent Other Assets Net DepositsAndOtherAssetsNoncurrentOtherAssetsNet	8460000
CY2023Q4	gevo	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	44319000
CY2022Q4	gevo	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	13692000
CY2023	gevo	Number Of Commitments With Collateral NumberOfCommitmentsWithCollateral	2
CY2023Q4	gevo	Deposits And Other Assets Noncurrent Deposits Receivable Reimbursed Or Used As Investment DepositsAndOtherAssetsNoncurrentDepositsReceivableReimbursedOrUsedAsInvestment	5500000
CY2023Q4	gevo	Deposits And Other Assets Noncurrent Deposits Receivable Fully Reimbursed Upon Completion DepositsAndOtherAssetsNoncurrentDepositsReceivableFullyReimbursedUponCompletion	28100000
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2718000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5009000
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	13411000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12594000
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6621000
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5105000
CY2023Q4	gevo	Accrued Sales And Use Tax Current AccruedSalesAndUseTaxCurrent	2000
CY2022Q4	gevo	Accrued Sales And Use Tax Current AccruedSalesAndUseTaxCurrent	2052000
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	22752000
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	24760000
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	68118000
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	67541000
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	68097000
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	159000
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	21000
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	67382000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	68089000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	29000
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	68118000
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	17087000
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	16935000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5945321
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.65
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y1M6D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3368717
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.69
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1204915
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.06
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8109123
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.51
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y9M18D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	3046060
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	4.80
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P8Y
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	3000000.0
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	48638000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	40511000
CY2023Q4	gevo	Deferred Tax Assets Operating Lease Assets DeferredTaxAssetsOperatingLeaseAssets	-405000
CY2022Q4	gevo	Deferred Tax Assets Operating Lease Assets DeferredTaxAssetsOperatingLeaseAssets	-371000
CY2023Q4	gevo	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	545000
CY2022Q4	gevo	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	410000
CY2023Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	11421000
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	9145000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2530000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2027000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards General Business DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness	1110000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards General Business DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness	1033000
CY2023Q4	gevo	Deferred Tax Assets Capitalized Research Cost DeferredTaxAssetsCapitalizedResearchCost	7332000
CY2022Q4	gevo	Deferred Tax Assets Capitalized Research Cost DeferredTaxAssetsCapitalizedResearchCost	3334000
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	820000
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	691000
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	71991000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	56780000
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	71991000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	56780000
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2023	gevo	Deferred Tax Assets Capitalized Research Costs Increase Decrease DeferredTaxAssetsCapitalizedResearchCostsIncreaseDecrease	3600000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.068
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.016
CY2023	gevo	Effective Income Tax Rate Reconciliation Officers Compensation Limit EffectiveIncomeTaxRateReconciliationOfficersCompensationLimit	-0.018
CY2022	gevo	Effective Income Tax Rate Reconciliation Officers Compensation Limit EffectiveIncomeTaxRateReconciliationOfficersCompensationLimit	-0.012
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.025
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.002
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.010
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.233
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.204
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2023Q1	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	1
CY2023Q1	gevo	Defined Contribution Plan Employer Matching Contribution Percent Of Employees Elective Contributions DefinedContributionPlanEmployerMatchingContributionPercentOfEmployeesElectiveContributions	0.03
CY2023Q1	gevo	Defined Contribution Plan Employer Matching Contribution Additional Percent Of Match DefinedContributionPlanEmployerMatchingContributionAdditionalPercentOfMatch	0.50
CY2023	gevo	Defined Contribution Plan Employer Accrued Matching Contributions DefinedContributionPlanEmployerAccruedMatchingContributions	700000
CY2023	us-gaap	Loss Contingency Loss In Period LossContingencyLossInPeriod	0
CY2023Q4	us-gaap	Accrual For Environmental Loss Contingencies AccrualForEnvironmentalLossContingencies	0
CY2023Q4	gevo	Number Of Long Term Fuel Supply Contracts NumberOfLongTermFuelSupplyContracts	3
CY2023Q4	us-gaap	Contractual Obligation ContractualObligation	36000000.0
CY2023	gevo	Number Of Commitments With Collateral NumberOfCommitmentsWithCollateral	2
CY2023Q4	gevo	Commitment Collateral Percentage Of Renewable Energy Credits CommitmentCollateralPercentageOfRenewableEnergyCredits	1
CY2023Q4	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	39989000
CY2023Q4	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	9976000
CY2023Q4	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	1847000
CY2023Q4	us-gaap	Purchase Obligation Due In Fourth Year PurchaseObligationDueInFourthYear	2188000
CY2023Q4	us-gaap	Purchase Obligation Due In Fifth Year PurchaseObligationDueInFifthYear	2330000
CY2023Q4	us-gaap	Purchase Obligation Due After Fifth Year PurchaseObligationDueAfterFifthYear	27516000
CY2023Q4	us-gaap	Purchase Obligation PurchaseObligation	83846000
CY2023Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	63333336
CY2023Q4	gevo	Common Shares Issued Upon Exercise Of Warrants CommonSharesIssuedUponExerciseOfWarrants	29914069
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	33419267
CY2023	gevo	Warrants Exercised WarrantsExercised	0
CY2023Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	25000000
CY2022	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0
CY2023	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0
CY2023Q4	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	0
CY2023Q4	gevo	Deposits And Other Assets Noncurrent Deposits Receivable DepositsAndOtherAssetsNoncurrentDepositsReceivable	33600000
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	17200000
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	19007000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-81835000
CY2023	us-gaap	Interest Income Domestic Deposits InterestIncomeDomesticDeposits	18957000
CY2023	us-gaap	Interest Expense InterestExpense	2161000
CY2023	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	54455000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1175000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7887000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-102686000
CY2022	us-gaap	Interest Income Domestic Deposits InterestIncomeDomesticDeposits	6118000
CY2022	us-gaap	Interest Expense InterestExpense	1167000
CY2022	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	84077000
CY2023Q4	us-gaap	Assets Assets	650322000
CY2022Q4	us-gaap	Assets Assets	700748000
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	gevo	Rule10b51 Arr Modified Flag Rule10b51ArrModifiedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	gevo	Non Rule10b51 Arr Modified Flag NonRule10b51ArrModifiedFlag	false

Files In Submission

Name	View Source	Status
0001392380-24-000008-index-headers.html	Edgar Link	pending
0001392380-24-000008-index.html	Edgar Link	pending
0001392380-24-000008.txt	Edgar Link	pending
0001392380-24-000008-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
gevo-20231231.xsd	Edgar Link	pending
gevo-20231231x10k.htm	Edgar Link	pending
gevo-20231231x10k005.jpg	Edgar Link	pending
gevo-20231231x10k006.jpg	Edgar Link	pending
gevo-20231231xex10d34.htm	Edgar Link	pending
gevo-20231231xex10d34001.jpg	Edgar Link	pending
gevo-20231231xex10d34002.jpg	Edgar Link	pending
gevo-20231231xex10d34003.jpg	Edgar Link	pending
gevo-20231231xex10d34004.jpg	Edgar Link	pending
gevo-20231231xex10d34005.jpg	Edgar Link	pending
gevo-20231231xex10d34006.jpg	Edgar Link	pending
gevo-20231231xex10d34007.jpg	Edgar Link	pending
gevo-20231231xex10d34008.jpg	Edgar Link	pending
gevo-20231231xex10d34009.jpg	Edgar Link	pending
gevo-20231231xex10d34010.jpg	Edgar Link	pending
gevo-20231231xex10d34011.jpg	Edgar Link	pending
gevo-20231231xex10d34012.jpg	Edgar Link	pending
gevo-20231231xex10d34017.jpg	Edgar Link	pending
gevo-20231231xex10d34018.jpg	Edgar Link	pending
gevo-20231231xex10d34019.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
gevo-20231231x10k_htm.xml	Edgar Link	completed
gevo-20231231xex10d34020.jpg	Edgar Link	pending
gevo-20231231xex10d34023.jpg	Edgar Link	pending
gevo-20231231xex10d34028.jpg	Edgar Link	pending
gevo-20231231xex10d34029.jpg	Edgar Link	pending
gevo-20231231xex10d34030.jpg	Edgar Link	pending
gevo-20231231xex10d34031.jpg	Edgar Link	pending
gevo-20231231xex10d34078.jpg	Edgar Link	pending
gevo-20231231xex10d34151.jpg	Edgar Link	pending
gevo-20231231xex10d34152.jpg	Edgar Link	pending
gevo-20231231xex10d34155.jpg	Edgar Link	pending
gevo-20231231xex10d34156.jpg	Edgar Link	pending
gevo-20231231xex10d34159.jpg	Edgar Link	pending
gevo-20231231xex10d34160.jpg	Edgar Link	pending
gevo-20231231xex10d34161.jpg	Edgar Link	pending
gevo-20231231xex10d34162.jpg	Edgar Link	pending
gevo-20231231xex10d34163.jpg	Edgar Link	pending
gevo-20231231xex10d34179.jpg	Edgar Link	pending
gevo-20231231xex10d35.htm	Edgar Link	pending
gevo-20231231xex10d36.htm	Edgar Link	pending
gevo-20231231xex10d37.htm	Edgar Link	pending
gevo-20231231xex21d1.htm	Edgar Link	pending
gevo-20231231xex23d1.htm	Edgar Link	pending
gevo-20231231xex31d1.htm	Edgar Link	pending
gevo-20231231xex31d2.htm	Edgar Link	pending
gevo-20231231xex32d1.htm	Edgar Link	pending
gevo-20231231xex97.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
gevo-20231231_def.xml	Edgar Link	unprocessable
gevo-20231231_lab.xml	Edgar Link	unprocessable
gevo-20231231_pre.xml	Edgar Link	unprocessable
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
gevo-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GEVO
Gevo, Inc. Stock $gevo

2024 Q1 Form 10-K Financial Statement

#000139238024000008 Filed on March 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GEVO Gevo, Inc. Stock $gevo

2024 Q1 Form 10-K Financial Statement

#000139238024000008 Filed on March 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GEVO
Gevo, Inc. Stock $gevo